Gentian Diagnostics ASA (OSL:GENT)
Norway flag Norway · Delayed Price · Currency is NOK
58.40
0.00 (0.00%)
Jul 11, 2025, 4:25 PM CET

Gentian Diagnostics ASA Revenue

Gentian Diagnostics ASA had revenue of 43.57M NOK in the quarter ending June 30, 2025, with 13.88% growth. This brings the company's revenue in the last twelve months to 163.38M, up 11.68% year-over-year. In the year 2024, Gentian Diagnostics ASA had annual revenue of 152.07M with 12.52% growth.

Revenue (ttm)
163.38M
Revenue Growth
+11.68%
P/S Ratio
5.51
Revenue / Employee
2.59M
Employees
63
Market Cap
900.67M

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 152.07M 16.92M 12.52%
Dec 31, 2023 135.15M 23.23M 20.76%
Dec 31, 2022 111.92M 11.91M 11.91%
Dec 31, 2021 100.01M 21.13M 26.78%
Dec 31, 2020 78.88M 23.50M 42.43%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Medistim ASA 603.92M
Nordhealth AS 545.88M
Photocure ASA 532.69M
Vistin Pharma ASA 440.66M
Omda AS 442.14M
ArcticZymes Technologies ASA 102.97M
Lytix Biopharma AS 608.00K
Nykode Therapeutics AS 87.09M
Revenue Rankings